Search for: "Deas v. State" Results 21 - 40 of 659
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Aug 2023, 6:00 pm by Kurt R. Karst
  The transfer of EPCS for initial dispensing is permissible only if allowable under existing State or other applicable law. [read post]
7 Aug 2023, 8:40 am by Delia A. Deschaine
This extension bought the DEA some time to consider and, as DEA Administrator Anne Milgram stated, to “work to find a way forward to give Americans that access with appropriate safeguards. [read post]
31 Jul 2023, 3:12 am by Kurt R. Karst
  Letter from Congress of the United States, to Robert Patterson, Acting Administrator, DEA (Dec. 21, 2017). [read post]
5 Jul 2023, 8:31 am by Kevin S. Little
Some of the most significant updates include the following: Registration Requirements Generally, every practitioner who dispenses, which includes by definition administering and prescribing, controlled substances in schedules II through V, must be registered with DEA. [read post]
30 Jun 2023, 1:14 pm by John Ross
What happens if a DEA agent has ample evidence of probable cause to search a car, but the New Hampshire police officer whom the DEA agent directs to actually do the search doesn't have that evidence? [read post]
14 Jun 2023, 8:38 am by Levin Papantonio
Walgreens liability depositions taken by Mougey and Gaddy have played in every trial against Walgreens in federal and state court.New Mexico v. [read post]
16 Apr 2023, 7:41 am by John Floyd
This case vividly illustrates the far-reaching divisions among federal and state courts about dealing with Bruton Rule-type cases since the Supreme Court decided Crawford v. [read post]
31 Mar 2023, 9:31 am by Aaron Black
In response to the PHE, Secretary Azar of the Department of Health and Human Services declared that DEA-registered practitioners in all areas of the United States may issue prescriptions for all schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation, provided all of the following conditions are met: The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his/her… [read post]
7 Mar 2023, 7:14 am by Alan J. Arville
Without final DEA rulemaking, at the end of the PHE, federal controlled substance prescribing requirements will revert to their pre-pandemic state. [read post]